報價延遲最少15分鐘:2026/02/09 19:06 EST
盤後時段
|
||||
|
5.94 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.98
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.97/5.44
|
|
企業價值
21.12B
|
| 資產負債 |
|
每股賬面淨值
-1.52
|
| 現金流量 |
|
現金流量率
0.69
|
| 損益表 |
|
收益
823.72M
|
|
每股收益
23.05
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reportsrevenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |
